Name: IQPC Patent Infringement Litigation Summit
Start: 2013-12-09T05:00

Why Fish

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Pricing

Legal Project Management

Knowledge Management

eDiscovery

Legal Technology Services

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Appellate

ITC Litigation & Section 337

Standard Essential Patents

Chancery & Corporate Governance

Post-Grant

Inter Partes Review

Post-Grant Review

Ex Parte Reexamination

Supplemental Examination

Patent

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Industries

Electrical & Computer Technology

Artificial Intelligence

Digital Health

Digital Media & E-Commerce

Financial, Business & FinTech Services

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Post-Grant Annual Reports

Christopher Marchese (San Diego) is scheduled to speak on a panel about patent damages at the Patent Infringement Litigation Summit.

Patent Damages Panel

Patent Infringement Litigation Summit

Life Science Legal Strategy Summit

Protecting Trade Secrets in Life Sciences

Quantum Computing Patent Enforcement: The Coming Challenges

UK Supreme Court Allows Tesla to Challenge Avanci’s 5G SEP Platform Rate

Patent Litigation Tactics for Cybersecurity Companies: Challenging Patents at the Patent Office

Forum Selection Clause Supports Early Termination of Trade Secret Investigation at the ITC

CAFC Clarifies "Skilled Searcher" Inquiry for IPR Estoppel

The UPC’s Emerging FRAND Framework

Is the Reverse Doctrine of Equivalents Alive and Well (Even if on Life Support)?

Senate Confirms 5 ITC Commissioners

Germany IP Rulings Clarify 'Willing' SEP Licensee Analysis